Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
出版年份 2022 全文链接
标题
Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
作者
关键词
-
出版物
Cardiovascular Diabetology
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-12-04
DOI
10.1186/s12933-022-01697-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Non‐alcoholic fatty liver disease and stroke: A Mendelian randomization study
- (2022) Min Wu et al. EUROPEAN JOURNAL OF NEUROLOGY
- Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
- (2022) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
- (2022) P. Barton Duell et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex
- (2022) Yasuhiro Matsubayashi et al. Cardiovascular Diabetology
- MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups
- (2022) Hyoeun Kim et al. DIGESTIVE DISEASES AND SCIENCES
- Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals
- (2022) Jingxuan Quek et al. Endocrine Practice
- American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
- (2022) Kenneth Cusi et al. Endocrine Practice
- The transition from NAFLD to MAFLD: One size still does not fit all—Time for a tailored approach?
- (2022) Laurens A. Kleef et al. HEPATOLOGY
- Effects of Experimental Sleep Restriction on Energy Intake, Energy Expenditure, and Visceral Obesity
- (2022) Naima Covassin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial
- (2022) Javier Delgado-Lista et al. LANCET
- Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis
- (2022) Naveed Sattar et al. NATURE MEDICINE
- SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease
- (2022) Jun Sung Moon et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Tirzepatide adds hepatoprotection to its armoury
- (2022) Giovanni Targher Lancet Diabetes & Endocrinology
- The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome
- (2022) Takumi Noda et al. Journal of Clinical Medicine
- Letter to the editor: Is NAFLD a bystander or contributor to coronary artery disease?
- (2022) Ziyu Xun et al. HEPATOLOGY
- A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population
- (2022) Ya-Cong Zhang et al. Hepatology International
- Promoting the term MAFLD: China in action
- (2022) Xin-Lei Zhang et al. Lancet Gastroenterology & Hepatology
- Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals
- (2022) Alessandro Mantovani et al. GUT
- Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial
- (2021) Anat Yaskolka Meir et al. GUT
- Management of non-alcoholic fatty liver disease
- (2021) Maria Letizia Petroni et al. BMJ-British Medical Journal
- Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
- (2021) Alessandro Mantovani et al. Metabolites
- MAFLD and cardiovascular events: what does the evidence show?
- (2021) Jacob George et al. Clinical Gastroenterology and Hepatology
- Treatments for NAFLD: State of Art
- (2021) Alessandro Mantovani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study
- (2021) Madunil Anuk Niriella et al. PLoS One
- Role of Insulin Resistance in MAFLD
- (2021) Yoshitaka Sakurai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999–2016
- (2021) Hao-Jie Zhang et al. CHINESE MEDICAL JOURNAL
- MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach
- (2021) Tsubasa Tsutsumi et al. HEPATOLOGY RESEARCH
- Association of MAFLD with diabetes, chronic kidney disease, and cardiovascular disease: a 4.6-year cohort study in China
- (2021) Yebei Liang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease
- (2021) Nobuharu Tamaki et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States
- (2021) Donghee Kim et al. JOURNAL OF HEPATOLOGY
- The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis
- (2021) Shanshan Liu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- PPAR control of metabolism and cardiovascular functions
- (2021) David Montaigne et al. Nature Reviews Cardiology
- Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
- (2021) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?—Results From NHANES III
- (2021) Qi Huang et al. Frontiers in Medicine
- Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD
- (2021) Vy H. Nguyen et al. Clinical Gastroenterology and Hepatology
- Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
- (2021) Giulio Marchesini et al. DIGESTIVE AND LIVER DISEASE
- Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease
- (2021) Seogsong Jeong et al. Gut and Liver
- Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease
- (2021) Joon Ho Moon et al. Gut and Liver
- Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case–control study
- (2021) Hui-Hui Liu et al. Hepatology International
- Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan
- (2021) Masato Yoneda et al. JOURNAL OF GASTROENTEROLOGY
- Diabetes and metabolic dysfunction-associated fatty liver disease
- (2021) Timothy M.E. Davis METABOLISM-CLINICAL AND EXPERIMENTAL
- A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
- (2021) Sven M. Francque et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis
- (2021) Xiao-Jing Zhang et al. Science Translational Medicine
- A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques
- (2021) Xiao-Jing Zhang et al. Science Translational Medicine
- Metabolic (dysfunction) associated fatty liver disease: more evidence and a bright future
- (2021) Ting-Yao Wang et al. Hepatobiliary Surgery and Nutrition
- Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis
- (2021) Kaneez Fatima et al. Clinics and Research in Hepatology and Gastroenterology
- Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases
- (2020) Jingjing Cai et al. CIRCULATION RESEARCH
- Daily Aspirin Use Associated With Reduced Risk for Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease
- (2020) Mateus Dornelles Severo Clinical Gastroenterology and Hepatology
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk
- (2020) Eugene Han et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
- (2020) Ze Chen et al. FREE RADICAL BIOLOGY AND MEDICINE
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
- (2020) Giovanni Targher et al. GUT
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- From NAFLD to MAFLD: Implications of a premature change in terminology
- (2020) Zobair M Younossi et al. HEPATOLOGY
- Comparison of MAFLD and NAFLD diagnostic criteria in real world
- (2020) Su Lin et al. LIVER INTERNATIONAL
- Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
- (2020) Tracey G Simon et al. GUT
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. Hepatology International
- Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
- (2020) Sven Francque et al. Nature Reviews Gastroenterology & Hepatology
- Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study
- (2020) Hokyou Lee et al. Clinical Gastroenterology and Hepatology
- AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review
- (2020) Zobair M. Younossi et al. GASTROENTEROLOGY
- Clinical utility of the MAFLD definition
- (2020) Kenneth I. Zheng et al. JOURNAL OF HEPATOLOGY
- The NAFLD‐MAFLD debate: Eminence vs evidence
- (2020) Yasser Fouad et al. LIVER INTERNATIONAL
- Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
- (2020) Alessandro Mantovani et al. Metabolites
- MAFLD and risk of CKD
- (2020) Dan-Qin Sun et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Genetic Inhibition of PCSK9 and Liver Function
- (2020) Antoine Rimbert et al. JAMA Cardiology
- Nonalcoholic Fatty Liver Disease and the Heart
- (2019) Eric P. Stahl et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus
- (2019) Lee-Lee Lai et al. DIGESTIVE DISEASES AND SCIENCES
- The Beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content
- (2019) Yftach Gepner et al. JOURNAL OF HEPATOLOGY
- The association between liver fat and systemic calcified atherosclerosis
- (2019) Bo Kyung Koo et al. JOURNAL OF VASCULAR SURGERY
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- (2019) Fernando Bril et al. DIABETES CARE
- Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease
- (2019) Stanley Khoo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis
- (2019) Yan Liu et al. Scientific Reports
- Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study
- (2019) Kuan Ken Lee et al. Lancet Gastroenterology & Hepatology
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
- (2019) Juhani Knuuti et al. EUROPEAN HEART JOURNAL
- Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials
- (2019) Iram Amanullah et al. POSTGRADUATE MEDICAL JOURNAL
- Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
- (2019) Mohammed Eslam et al. Nature Reviews Gastroenterology & Hepatology
- Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
- (2019) Myriam Alexander et al. BMJ-British Medical Journal
- Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study
- (2019) Francesco Baratta et al. Clinical Gastroenterology and Hepatology
- Heart Failure After Ischemic Stroke or TIA in Insulin-Resistant Patients Without Diabetes Treated with Pioglitazone
- (2018) Lawrence H. Young et al. CIRCULATION
- Diabetic Cardiomyopathy
- (2018) Guanghong Jia et al. CIRCULATION RESEARCH
- Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases
- (2018) Maria Angela Incalza et al. VASCULAR PHARMACOLOGY
- Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36-month clinical trial
- (2018) Paola Portillo-Sanchez et al. Journal of Diabetes
- The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity
- (2018) Javier Ampuero et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease
- (2018) Omar A Mesarwi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Role of PCSK9 in the Pathogenesis of Non-alcoholic Fatty Liver Disease and the Effect of PCSK9 Inhibitors
- (2018) Eleni Theocharidou et al. CURRENT PHARMACEUTICAL DESIGN
- PNPLA3, TM6SF2, and MBOAT7 Genotypes and Coronary Artery Disease
- (2017) Nynke Simons et al. GASTROENTEROLOGY
- Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
- (2017) Leon A Adams et al. GUT
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Exercise-based Interventions for Nonalcoholic Fatty Liver Disease: A Meta-analysis and Meta-regression
- (2016) Lorenzo A. Orci et al. Clinical Gastroenterology and Hepatology
- Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis
- (2016) Kathleen E. Corey et al. DIGESTIVE DISEASES AND SCIENCES
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- Predicting Coronary Heart Disease Using Risk Factor Categories for a Japanese Urban Population, and Comparison with the Framingham Risk Score: The Suita Study
- (2016) Kunihiro Nishimura et al. Journal of Atherosclerosis and Thrombosis
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic Fatty Liver Disease and Incident Cardiac Events
- (2016) Irfan Zeb et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
- (2016) Jessica Glen et al. BMJ-British Medical Journal
- Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
- (2016) Jessica Glen et al. BMJ-British Medical Journal
- Quantifying the Association Between Physical Activity and Cardiovascular Disease and Diabetes: A Systematic Review and Meta‐Analysis
- (2016) Ahad Wahid et al. Journal of the American Heart Association
- Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis
- (2016) Shunquan Wu et al. Scientific Reports
- Comparative efficacy of anti-diabetic agents on nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized and non-randomized studies
- (2015) Wenjuan Tang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study
- (2015) Vincent Wai-Sun Wong et al. HEPATOLOGY
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials
- (2015) Ken Sato et al. NUTRITION
- Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis
- (2014) Juan Du WORLD JOURNAL OF GASTROENTEROLOGY
- Does vitamin E improve the outcomes of pediatric nonalcoholic fatty liver disease? A systematic review and meta-analysis
- (2014) AhmedA. Sarkhy et al. Saudi Journal of Gastroenterology
- Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
- (2014) Hannele Yki-Järvinen Lancet Diabetes & Endocrinology
- Methods of accelerated atherosclerosis in diabetic patients
- (2013) Gerard Pasterkamp HEART
- Dose Response Between Physical Activity and Risk of Coronary Heart Disease
- (2011) Jacob Sattelmair et al. CIRCULATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search